Active Smart Wearable Orthosis for Enhanched Rehabilitation THErapy
NCT ID: NCT03153254
Last Updated: 2018-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2017-09-15
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke
NCT01723046
Robot-based Therapy for Upper Limb Sensorimotor Impairments After Stroke
NCT05007002
Effects of the Action Observation Therapy and Robotic Rehabilitation on the Upper-Limb Motor Function in Stroke
NCT05590156
Personalized Wearable Robotics for Upper-limb Motor Rehabilitation in Neurological Patients. A Pilot Study.
NCT07316218
Wearable Robotic Functional Assistance for Stroke Rehabilitation
NCT00396708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this pilot study, the usability of a new upper arm RAT device for upper arm rehabilitation in stroke patients is investigated. Myo-electrical signals will serve as input for the device, assisting the user in flexion and extension of the elbow, which is combined with a stabilizing shoulder brace and a bionic glove.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy persons
Test upper limb robot assisted therapy device. During 1 session of 1/2 hour.
Test upper limb robot assisted therapy device
During 1 session of 1/2 hour.
Stroke patients
Training with new upper limb robot assisted therapy device. During 2 to 5 sessions of 1/2 hour.
Training with new upper limb robot assisted therapy device
During 2 to 5 sessions of 1/2 hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test upper limb robot assisted therapy device
During 1 session of 1/2 hour.
Training with new upper limb robot assisted therapy device
During 2 to 5 sessions of 1/2 hour.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to sit on a chair with adequate trunk stability
* Ability to follow verbal instructions
* Ability to communicate verbally with the researchers
* Stroke patients, more than three months after onset
* Aged between 18 and 85 years
* None to moderate spasticity in the hemiplegic arm (Modified Ashworth Scale: 0-2)
* Detectable voluntary muscle activity at elbow flexion and elbow extension of the hemiplegic arm (Medical research council score: 1-5)
* Ability to sit on a chair with adequate trunk stability
* Ability to follow verbal instructions
* Ability to communicate verbally with the researchers
Exclusion Criteria
* Ever had a surgery in the upper limbs
* Pain in the upper limbs obstructing the execution of daily activities with the upper limbs
* Physical trauma in the two months preceding the research
* Mental problems that make the execution of daily activities unreliable
* (Chronic) subluxation of the shoulder joint
* Secundary soft tissue problems which may complicate the research or make it impossible (e.g. shoulder impingement, musculoskeletal problems, sensory deficits)
* Pregnancy
* Pacemaker
* Known allergies for one of the components of the ARTHE rehabilitation tool
2. Stroke patients:
* Stroke patients, less than three months after onset
* Massive spastic patterns
* Severe medical conditions that interfere with the proper execution of the research, patients who are medically unstable
* Cognitive disorders which may complicate the research or make it impossible
* Speaking disorders (aphasia, dysarthria) which may complicate the proper execution of the research and the communication of important verbal information
* Visual disorders which may complicate the research or make it impossible
* (Chronic) subluxation of the shoulder joint
* Shoulder-hand-syndrom
* Pusher syndrom
* Secundary soft tissue problems which may complicate the research or make it impossible (e.g. shoulder impingement, musculoskeletal problems, sensory deficits)
* Pregnancy
* Pacemaker
* Known allergies for one of the components of the ARTHE rehabilitation tool
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ortho-Medico
UNKNOWN
Thomas More Kempen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lieven De Maesschalck
Innovation Manager
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lieven De Maesschalck
Role: PRINCIPAL_INVESTIGATOR
Thomas More Kempen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
RevArthe
Edegem, Antwerp, Belgium
Thomas More - Mobilab
Geel, Antwerp, Belgium
REVAlution
Herentals, Antwerp, Belgium
Revalidatie & MS Centrum
Overpelt, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Christhophe Lafosse, Prof.
Role: primary
Martine Verhoeven
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S60144
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.